About Tagomics
Tagomics is a company based in Birmingham (United Kingdom) founded in 2020. Tagomics has raised $8.45 million across 2 funding rounds from investors including Agilent, Mercia and Calculus Capital. Tagomics offers products and services including Interlace. Tagomics operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Birmingham, United Kingdom
- SectorsHealthcare
- Website tagomics.com
- Social LinkedIn X
- Legal Name Tagomics Ltd
- Date of Incorporation 22 Jul, 2020
- Jurisdiction COVENTRY, ENGLAND
- Total Equity Funding$8.45M (USD)
in 2 rounds
- Latest Funding Round$1.17M (USD), Grant
Jun 2025
- InvestorsAgilent
& 8 more
Products & Services of Tagomics
Tagomics offers a comprehensive portfolio of products and services, including Interlace.
Enables identification of disease-associated DNA biomarkers from various samples.
Funding Insights of Tagomics
Tagomics has successfully raised a total of $8.45M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.17 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.45M
- Total Rounds 2
- Last Round Grant — $1.17M
- First Round $8.45M
(Feb 2024)
- Investors Count 9
All 2 funding rounds of Tagomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2025 | $1.17M | Grant | – | – | |
| Feb 2024 | $8.45M | Series A | – | Calculus Capital |
9 investors in total: 9 institutional.
Investors in Tagomics
Tagomics has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Agilent, Mercia and Calculus Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
UK venture capital investments are managed by Calculus Capital. | 1999 | calculuscapital.com | London, United Kingdom | |
Health tech startups are invested in by Illumina Ventures. | – | illuminaventures.com | Foster City, United States | |
Deep tech venture capital firm investing in European and global startups. | – | iqcapital.vc | - | |
Investment funding is provided to support Midlands SMEs growth. | – | meif.co.uk | Sheffield, United Kingdom | |
Venture capital investments are made in transformative biotech companies by OMX Ventures. | – | omx.vc | Lincolnshire, USA | |
Diversified instruments are developed for scientific and laboratory management. | 1995 | agilent.com | Santa Clara, United States | |
Investment management services are provided by Mercia to various clients. | 1982 | mercia.co.uk | - | |
Offers medical advisory services for the life science and biopharma industries. | 2014 | meltwind.co.uk | Cambridge, United States | |
Research and innovation funding is managed for UK advancement. | 2018 | ukri.org | Swindon, United Kingdom |
Investor details for Tagomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tagomics
5 people are tracked at Tagomics (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Jack Kennefick | Co-founder, Director And Chief Executive Officer | Leadership |
Rob Neely | Chief Scientific Officer | Leadership |
Debora Lucarelli | Chief Technology Officer | Leadership |
Anthony Smith | Director Of Computational Technology | Leadership |
Shirong Yu | Principal Scientist | Team |
Complete people profiles for Tagomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Tagomics
3 dated milestones of Tagomics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Tagomics is founded.
- Funding First funding round of $8.4M.
- Funding Latest funding round, Grant, of $1.2M.
Competitors of Tagomics
Tagomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| strandls.com | 2000 | Bengaluru, India | $34.88M | 532 | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | |
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| veracyte.com | 2008 | San Francisco, United States | $67.9M | 815 | Genomics-based diagnostic tests for cancer are developed. | |
| delfidiagnostics.com | 2019 | Baltimore, United States | $331.59M | – | Provider of DNA sequencing for cancer detection | |
| billiontoone.com | 2015 | San Francisco, United States | $388.62M | 47 | Provider of cell-free cancer liquid biopsy test |
Detailed competitors of Tagomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tagomics
Complete news archive for Tagomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Tagomics
10 companies that operate in the same segment as Tagomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tagomics
Tagomics was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Tagomics is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
Tagomics is a funded company, having raised a total of $8.45M across 2 funding rounds to date. The company's 1st funding round was a Series A of $8.45M, raised on Feb 2024.
Tagomics was founded in 2020 and is headquartered in Birmingham, United Kingdom. Operations are centered in the biotechnology sector, where a genomic-based cancer diagnostic platform is developed. Non-invasive blood tests are utilized to capture unmodified genome locations, with analysis focused on changes that occur during cancer progression. Services are provided to support early detection in oncology diagnostics.
Tagomics's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Tagomics offers Interlace.
Tagomics has 9 investors. Key investors include Agilent, Mercia, Calculus Capital, UK Research and Innovation, and Illumina Ventures.
Tagomics operates through Tagomics Ltd.